Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections

Details for Australian Patent Application No. 2006339058 (hide)

Owner Targanta Therapeutics Inc.

Inventors Rafai Far, Adel; Lafontaine, Yanick; Reddy, Ranga; Dietrich, Evelyne; Rose, Yannick Stephane; Kang, Ting; Ciblat, Stephane

Agent Shelston IP

Pub. Number AU-B-2006339058

PCT Pub. Number WO2007/096703

Priority 60/707,145 11.08.05 US

Filing date 11 August 2006

Wipo publication date 30 August 2007

Acceptance publication date 6 September 2012

International Classifications

C07F 9/6561 Compounds containing elements of the 5th Group of the Periodic System

A61K 31/5383

A61K 31/675 - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61P 19/00 Drugs for skeletal disorders

A61P 31/04 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 498/18 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/096703 Priority application(s): WO2007/096703

6 September 2012 Application Accepted

  Published as AU-B-2006339058

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006339063-Macro-diacrylates and macropolyacrylates

2006339057-Methods for multiplexing recombinase polymerase amplification